BridgeMD
New treatment option for Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Official title Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
ClinicalTrials.gov ID: NCT07180901
What this study is testing
- What it's testing
- Delays between surgery and the initiation of post-operative radiotherapy (S-PORT) in head and neck cancer (HNC) patients are prevalent and associated with worse oncologic outcomes. This pilot study evaluates whether a proactive, automated care coordination system (PRONTO-HN) can improve adherence to recommended S-PORT intervals of ≤42 days at the Centre hospitalier de l'Université de Montréal (CHUM).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All adult patients (age 18 or older).
- Pathologically confirmed oral cavity or laryngeal squamous cell carcinoma.
- Diagnosed from July 2024 to September 2026.
- With planned primary intention surgical resection.
- With or without adjuvant therapy.
You likely can't join if
- Patients who do not end up receiving surgery.
- S-PORT \> 180 days
See the full eligibility criteria
- All adult patients (age 18 or older).
- Pathologically confirmed oral cavity or laryngeal squamous cell carcinoma.
- Diagnosed from July 2024 to September 2026.
- With planned primary intention surgical resection.
- With or without adjuvant therapy.
- Treated at the Centre Hospitalier de l'Université de Montréal.
- Patients who do not end up receiving surgery.
- S-PORT \> 180 days
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.